News

Charles & Colvard, Ltd. Addresses Nasdaq Compliance Notification

Charles & Colvard, Ltd. Addresses Nasdaq Compliance Notification

Charles & Colvard, Ltd. Addresses Nasdaq Compliance Notification

Charles & Colvard, Ltd. (Nasdaq: CTHR), known for its ethical jewelry practices, recently received a notice from the Nasdaq Stock Market regarding its compliance status. The Company was informed that it remains out of compliance with Nasdaq Listing Rule 5250(c)(1) because it has not timely filed its Quarterly Report on Form 10-Q for the fiscal quarter that concluded on December 31, 2024. This notice was expected as part of Charles & Colvard's ongoing commitment to transparency and compliance.

On February 25, 2025, the Nasdaq Listing Qualifications Department communicated that while the Company is working towards filing its overdue reports, it has until April 14, 2025, to file both its Annual Report on Form 10-K for the year ending June 30, 2024, and the overdue Form 10-Q for the quarter ending September 30, 2024. The Nasdaq has made it clear that Charles & Colvard must submit an update to its compliance plan by March 12, 2025, which is an important step in demonstrating its commitment to resolving these delays.

Importantly, this notice does not currently affect the trading of the Company’s common stock on Nasdaq. Charles & Colvard’s management is dedicated to addressing these compliance issues swiftly and efficiently. The team is diligently preparing the necessary documentation to ensure that it adheres to the regulatory requirements and restores its compliance status.

Commitment to Ethical Practices

At the heart of Charles & Colvard’s identity is a dedication to ethics and sustainability in the jewelry industry. The Company pioneered lab-grown moissanite, creating an innovative and ethical alternative to traditional gemstones. Charles & Colvard maintains that fine jewelry should not only be beautiful but also ethically produced, utilizing exclusively Made, not Mined™ above ground gemstones. This commitment is evident in the creation of their flagship products, such as the Forever One™ moissanite and Caydia® lab-grown diamonds, which showcase exceptional quality while promoting environmental responsibility.

The Value Proposition

Charles & Colvard’s philosophy centers around offering stunning gemstones at accessible price points, reflecting its commitment to providing true value to its customers. By using 100% recycled precious metals and ethically sourced lab-grown materials, the Company is setting a standard in the fine jewelry market. Consumers are increasingly aware of the environmental impacts of traditional mining practices, making Charles & Colvard’s offerings more appealing to those seeking ethical consumption.

Ongoing Efforts Towards Compliance

In light of the Nasdaq’s notice, Charles & Colvard emphasizes its focus on the timely completion of its outstanding financial reports. The Company acknowledges the importance of adhering to rules set forth by regulatory bodies like Nasdaq and is proactively communicating its progress in this area to its stakeholders. By ensuring regulatory compliance, Charles & Colvard aims to enhance shareholder trust and maintain its positive market standing.

Future Outlook

As the Company works through its obligations, its management team remains optimistic about regaining compliance, believing in its operational strength and business model. Charles & Colvard’s leadership is engaged in reassessing internal processes to better navigate the requirements set by the Nasdaq and improve reporting efficiencies moving forward. This strategic pivot not only aims to resolve current issues but also equips the Company for long-term success.

Frequently Asked Questions

What was the Nasdaq notice received by Charles & Colvard?

Charles & Colvard received a notice from Nasdaq indicating it was out of compliance due to the late filing of its Form 10-Q.

What actions is Charles & Colvard taking in response to the notice?

The Company is actively working to prepare and submit the overdue reports to regain compliance with Nasdaq regulations.

How does this notice affect the trading of the Company's stock?

The notice does not currently affect the ability to trade Charles & Colvard’s common stock on Nasdaq.

What is the focus of Charles & Colvard's products?

Charles & Colvard specializes in lab-grown gemstones and ethically sourced jewelry, advocating sustainable practices in the industry.

When does Charles & Colvard need to submit its compliance update?

The Company must submit an update on its compliance plan by March 12, 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MedStar's Non-Invasive Tech Shakes Up Treatment World

Updated Category News Views 63

Incisionless Relief: A New Dawn for Neurological Care? Imagine being able to shed a neurological burden with nothing more than sound waves. That's exactly where we're heading with MedStar Health's latest offering. They're rolling out incisionless, MRI-guided ultrasound technology targeting essential tremor and Parkinson's disease. This isn't just tinkering under the hood;...

Continue Reading
NextPlat Gears Up for Q3 2026 Earnings Call

Updated Category News Views 40

NextPlat's Upcoming Financial Revelation November is shaping up to be a month of revelations for NextPlat Corp (NASDAQ:NXPL) as they prepare to spill the beans on their third-quarter 2026 financials. The number crunching wraps up at 8:30 a.m. Eastern on November 12, when the execs will host an investor conference call. The Details of the Big Day Coming to you live from...

Continue Reading
Silversea Opens World's Southernmost Hotel in Chile

Updated Category News Views 59

Launching into the Frozen Frontier Roll out the red carpet—or should I say, the white one—because Silversea's just dropped a hospitality bombshell down at the ends of the Earth. The Cormorant at 55 South flung its doors wide open, setting Puerto Williams, Chile, in the limelight. And boy, it's making waves. We're talking about the southernmost hotel on this spinning...

Continue Reading
Mount St. Mary’s University Secures Future for High Schoolers

Updated Category News Views 45

Breaking Ground: Education Made Accessible Boy, oh boy, this move between Mount St. Mary’s University and Saint John Vianney High School is something that just warmed up my trading heart like a surprise market rally. They've inked a deal—a Memorandum of Understanding (MOU)—to fling open the doors to higher education for high schoolers who've got their eyes on the...

Continue Reading
Faith Leaders Reject Dominion-NextEra $67B Merger

Updated Category News Views 138

Voices Raised Against a Corporate Giant Today, outside the drab halls of the Virginia State Corporation Commission (SCC), a group of faith leaders drew a line in the sand against a looming energy giant. The $67 billion move to merge Dominion Energy with NextEra Energy ignited their rallying cry. Phooey to sacrificing community well-being for corporate greed, they shouted....

Continue Reading
UN's AI Toolbox Aims to Keep City Oversight Human

Updated Category News Views 68

Artificial Intelligence: Tool or Tyrant? Ever feel like we're on a runaway train with this AI business in city management? The United Nations seems to think so, and it’s stepping in with a big red STOP sign—or rather, a toolbox. This week, in a grand procession at Barcelona's Smart City Expo, they rolled out the United for Smart Sustainable Cities (U4SSC) Toolbox,...

Continue Reading
Lululemon Faces Class Action Amid Sales Decline

Updated Category News Views 99

Looks like Lululemon Athletica Inc. (NASDAQ: LULU) is in the hot seat, and not in the cozy yoga session kind of way. Investors are gearing up for a legal face-off thanks to a class action lawsuit alleging some serious corporate sleight of hand. What Triggered This Legal Storm? Turns out, between March 18 and September 3, 2026, things didn't go as planned for Lululemon....

Continue Reading
Kestrel Group Faces Financial Hit Despite Revenue Growth

Updated Category News Views 36

Kestrel's Financial Rollercoaster Continues Here's the deal with Kestrel Group, folks. They just dropped their Q3 2026 financials, and it's a mixed bag. The top line's looking solid with total revenues hitting $4.8 million, riding high on a 203% jump in Program Services fee income. But dig a little deeper, and there's a $16.4 million net loss staring us in the face....

Continue Reading
VS Pharmtech Enhances Cancer Drug Efficiency, Eyes IPO

Updated Category News Views 68

Revolutionizing Cancer Care, One Dose at a Time Now, here's a twist worth chewing over your morning coffee: VS Pharmtech isn't concocting some newfangled miracle drug but is instead jazzing up the old ones. Their creation, VS-101, isn't just another treatment—it's a radiosensitizer designed to make existing therapies more potent without the toxic baggage. The Science...

Continue Reading
Mynd.ai Alters ADS Ratio Affecting Share Dynamics

Updated Category News Views 60

Analyzing Mynd.ai's ADS Ratio Tweak When Mynd.ai decides to shake things up with the American Depositary Shares (ADS) ratio, it's like they're throwing a curveball straight at Wall Street. Listen up, this isn't just a deck shuffle—it's a fundamental tweak that could play a big role in the stock’s perceived value. Starting December 7, 2027, one ADS will leap from...

Continue Reading

Top 5 Most Recently Viewed Articles

Teva Expands Debt Tender Offer to Support Financial Stability

Updated Category News Views 170

Teva's Strategic Debt Tender Offer Enhancement Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has recently announced significant updates to its debt tender offer designed to bolster its financial positioning. The company is raising its maximum tender amount from $2.0 billion to approximately $2.25 billion in aggregate cash purchase, excluding any accrued...

Continue Reading
Investigation into Telix Pharmaceuticals' Possible Claims

Updated Category News Views 99

Investigation into Telix Pharmaceuticals In recent news, the national securities law firm Faruqi & Faruqi, LLP has initiated an investigation regarding potential claims involving Telix Pharmaceuticals Limited. This investigation aims to provide support for investors who might have suffered losses related to their holdings in Telix. Please Act Soon Investors are advised to...

Continue Reading
J.M. Smucker Co. Announces Generous Dividend for Shareholders

Updated Category News Views 122

J.M. Smucker Co. Declares Substantial Dividend Today marks a significant moment for shareholders of The J.M. Smucker Co. as the Board of Directors has approved a remarkable dividend of $1.10 per share on the common shares of the Company. This announcement reflects the company's robust financial performance and commitment to returning value to its shareholders over time....

Continue Reading
Mercantile Reports Strong Q2 2026, Net Income Up 14.2%

Updated Category News Views 50

Mercantile's Impressive Second Quarter Mercantile Bank Corporation (NASDAQ: MBWM) struts into the second quarter of 2026 with some meaty numbers that should make any investor smirk with satisfaction. Net income hit $25.9 million, up from last year's $22.6 million. That's a robust 14.2% growth in net income, all while the world around us seemed ready to tip off a cliff...

Continue Reading
Critical Investigation Into Aviat Networks: Know Your Rights

Updated Category News Views 93

Investigation Into Aviat Networks: Your Options Block & Leviton is currently looking into possible violations of securities laws involving Aviat Networks, Inc. (NASDAQ: AVNW). If you’re an investor impacted by these developments, it’s a good idea to reach out to the firm to discuss how you might recover your financial losses. What’s Happening? Aviat Networks has...

Continue Reading